Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;20(5):470-480.
doi: 10.1007/s12519-023-00794-8. Epub 2024 Feb 15.

Factors affecting length of stay according to bronchopulmonary dysplasia severity: a nationwide cohort study in Korea

Affiliations

Factors affecting length of stay according to bronchopulmonary dysplasia severity: a nationwide cohort study in Korea

Hye Mi Lee et al. World J Pediatr. 2024 May.

Abstract

Background: Longer hospitalizations for preterm infants with bronchopulmonary dysplasia (BPD) delay developmental outcomes, increase the risk for hospital-acquired complications, and exert a substantial socioeconomic burden. This study aimed to identify factors associated with an extended length of stay (LOS) at different levels of severity of BPD.

Methods: A cohort study was conducted using the Korean Neonatal Network registry of very low birth weight infants with BPD between 2013 and 2017 through retrospective analysis.

Results: A total of 4263 infants were diagnosed with BPD. For mild BPD, infants requiring surgical treatment for patent ductus arteriosus needed a longer LOS [eadjusted β coefficients (adj β) 1.041; 95% confidence interval (CI): 0.01-0.08] and hydrocephalus (eadj β 1.094; 95% CI 0.01-0.17). In moderate BPD, infants administered steroids or with intraventricular hemorrhage required a longer LOS (eadj β 1.041; 95% CI 0.00-0.07 and eadj β 1.271; 95% CI 0.11-0.38, respectively). In severe BPD, infants with comorbidities required a longer LOS: pulmonary hypertension (eadj β 1.174; 95% CI 0.09-0.23), administrated steroid for BPD (eadj β 1.116; 95% CI 0.07-0.14), sepsis (eadj β 1.062; 95% CI 0.01-0.11), patent ductus arteriosus requiring surgical ligation (eadj β 1.041; 95% CI 0.00-0.08), and intraventricular hemorrhage (eadj β 1.016; 95% CI 0.05-0.26). Additionally, the higher the clinical risk index score, the longer the LOS needed for infants in all groups.

Conclusions: The factors affecting LOS differed according to the severity of BPD. Individualized approaches to reducing LOS may be devised using knowledge of the various risk factors affecting LOS by BPD severity.

Keywords: Bronchopulmonary dysplasia; Length of stay; Very low birth weight.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.

Figures

Fig. 1
Fig. 1
Flow chart of study population. This presents a flowchart of the inclusion and exclusion criteria of our study. Analyzed data [n = 4263; mild bronchopulmonary dysplasia (BPD) = 2132, moderate BPD = 887, and severe BPD = 1244] were obtained from the Korean Neonatal Network (KNN) Database, 2013–2017. GA gestational age, NICU neonatal intensive care unit, PICU pediatric intensive care unit
Fig. 2
Fig. 2
Length of stay according to BPD severity. The length of stay increases with bronchopulmonary dysplasia (BPD) severities: 75.1 ± 21.3 days in the mild BPD group, 84.2 ± 25.5 days in the moderate BPD group, and 111.6 ± 40.3 days in the severe BPD group. *P < 0.001

References

    1. Zeitlin J, Szamotulska K, Drewniak N, Mohangoo A, Chalmers J, Sakkeus L, et al. Preterm birth time trends in Europe: a study of 19 countries. BJOG. 2013;120:1356–1365. doi: 10.1111/1471-0528.12281. - DOI - PMC - PubMed
    1. Howson CP, Kinney MV, McDougall L, Lawn JE, Group BTSPBA. Born too soon: preterm birth matters. Reprod Health. 2013;10:1–9. - PMC - PubMed
    1. Stensvold HJ, Klingenberg C, Stoen R, Moster D, Braekke K, Guthe HJ, et al. Neonatal morbidity and 1-year survival of extremely preterm infants. Pediatrics. 2017;139:e20161821. doi: 10.1542/peds.2016-1821. - DOI - PubMed
    1. Northway WH, Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. NEJ M. 1967;276:357–368. doi: 10.1056/NEJM196702162760701. - DOI - PubMed
    1. Xu YP, Shi LP, Du LZ. Continuing interventions in a quality improvement bundle to reduce bronchopulmonary dysplasia. World J Pediatr. 2022;18:278–282. doi: 10.1007/s12519-021-00508-y. - DOI - PubMed

LinkOut - more resources